United States Supreme Court (1 summary)
Merck Sharp & Dohme Corp. v. Albrecht
Absence of 鈥渃lear evidence that the FDA would not approve a change to a label, the Court will not conclude that it was impossible鈥 to comply with both federal and state requirements.鈥
Area(s) of Law:- Preemption